PT-141 10mg – Research Use Only

For research use only. Not for human consumption. Not for veterinary use. Not a medicinal product.

PT-141, also known as bremelanotide, is a synthetic cyclic heptapeptide that has been investigated in scientific research involving melanocortin receptors and related biochemical pathways. It is a synthetic peptide analogue associated with melanocortin receptor activity and has been examined in a range of pharmacological and experimental research settings. PT-141 is therefore of interest to laboratories studying peptide structure, receptor interactions and cellular signalling mechanisms.

Product Overview

PT-141 is supplied as a laboratory research compound for use by suitably qualified researchers conducting controlled scientific investigations. Research interest in this peptide is primarily associated with its interaction with melanocortin receptors, including MC3R and MC4R. Scientific studies have examined the pharmacological characteristics of bremelanotide and its interaction with these receptor systems, providing researchers with a defined compound for investigating melanocortin-related mechanisms.

The compound has been investigated in published research involving pharmacokinetic, pharmacodynamic and receptor-related studies. Such research provides information about the characteristics and behaviour of the compound under specific experimental conditions. Findings from scientific studies should always be considered within the context of the particular research model used and should not be interpreted as evidence of suitability, efficacy or safety for human or veterinary use.

This product is supplied solely as a research material. It is not supplied as a food, food supplement, cosmetic, medicine, veterinary medicine or therapeutic product. No claims are made that PT-141 can diagnose, treat, cure, prevent or alleviate any disease, illness or medical condition.

Research Applications

For suitably qualified researchers, PT-141 may be of interest in areas including peptide chemistry, analytical chemistry, receptor pharmacology and biochemical research. Potential laboratory investigations may include peptide identification, analytical characterisation, stability assessment, receptor-binding research and controlled studies examining interactions with melanocortin-related pathways.

Researchers should independently determine whether the material is appropriate for their intended experimental application. Appropriate laboratory procedures, validated analytical methods, suitable personal protective equipment and relevant safety controls should be used when handling research compounds.

No instructions for administration, dosage or personal use are provided with this product. It is intended exclusively for legitimate laboratory research conducted by appropriately qualified personnel and under suitable controlled laboratory conditions.

Product Characteristics

Product: PT-141
Alternative name: Bremelanotide
Classification: Synthetic cyclic heptapeptide
Research area: Melanocortin receptor research
Product type: Research compound
Quantity: 10mg

PT-141 should be distinguished from finished medicinal products containing bremelanotide. Although the same active compound may be referenced in pharmaceutical literature, a research-grade material supplied through this website is not represented as an authorised medicinal product. Its inclusion in scientific and pharmaceutical literature does not change the intended research-only status of the material supplied here.

UK Regulatory Notice

The regulatory status of products in the UK can depend on factors including intended purpose, presentation, wording, pharmacological properties and claims made through packaging, websites, advertising and promotional material. Both explicit and implicit claims may be relevant when determining whether a product falls within the definition of a medicinal product.

Accordingly, this listing is deliberately limited to factual research information. PT-141 is presented solely as a research compound and is not marketed as a treatment, medicine, supplement or product intended to modify health or physiological function in consumers.

The research material should be handled and stored appropriately by qualified personnel in accordance with applicable laboratory procedures and relevant safety requirements. Users are responsible for ensuring that their intended research activities comply with applicable legislation and institutional requirements.

For research use only. Not for human consumption. Not for veterinary use. Not a medicinal product. Not intended to diagnose, treat, cure or prevent any disease or medical condition.